Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 Solid Net Profit Margin Stocks to Boost Portfolio Returns [Yahoo! Finance]
Independent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences' DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with Melanoma [Yahoo! Finance]
Independent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences’ DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with Melanoma
Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference [Yahoo! Finance]